Prosecution Insights
Last updated: October 25, 2026

Entax Biomedicals Co. Ltd.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Entax Biomedicals Co. Ltd. is active in the Medical Devices & Mechanical Engineering technology area. The company has 1 pending office action, which is assigned to 1 distinct examiner and 1 distinct art unit. This indicates a singular focus in the company's current patent prosecution, with all activity concentrated on 1 specific matter.

KALIHER, HANS CHRISTIAN is the busiest examiner for the portfolio, responsible for 1 pending office action. Prosecution is currently focused on this 1 examiner, allowing for a streamlined communication process. The company does not have to manage multiple conflicting timelines or different examiner preferences across its current pending matters.

The use of 1 distinct art unit suggests that the technology being patented is highly specialized within the medical devices and mechanical engineering field. Practitioners can focus their strategy on the specific examination trends of this 1 unit and examiner. Although the portfolio currently has only 1 pending action, the centralized nature of the prosecution provides a clear focus for the company's immediate patenting goals.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KALIHER, HANS CHRISTIAN 1 62.9% +27.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19068278 Artificial intestinal device and surgical method using the same KALIHER, HANS CHRISTIAN —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19068278 Artificial intestinal device and surgical method using the same KALIHER, HANS CHRISTIAN —

Top Art Units

Art UnitApps
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19068278 Artificial intestinal device and surgical method using the same KALIHER, HANS CHRISTIAN 3781 §101§112 Non-Final OA — Pending Mar 03, 2025

Managing Entax Biomedicals Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Entax Biomedicals Co. Ltd. have?

Entax Biomedicals Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Entax Biomedicals Co. Ltd. applications?

Hans Christian Kaliher has the most, with 1 of Entax Biomedicals Co. Ltd.'s pending office actions.

What technology area are Entax Biomedicals Co. Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month